secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mirum Pharmaceuticals, Inc. (MIRM)
CIK:        0001759425
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0001193125-23-067794
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Mirum reports immaterial SVB exposure (<1% of cash)
---------------------------------------------------

- Less than 1% of cash, equivalents, restricted cash and investments held at SVB.
- SVB placed under FDIC receivership; company believes exposure is immaterial.
- May experience delays in transferring funds due to banking system disruption.
- No other financial impact disclosed as of March 10, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759425/000119312523067794/0001193125-23-067794-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759425/000119312523067794/d475671d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-067794

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer